Golexanolone is currently under development for the treatment of two disorders –
Primary Biliary Cholangitis (PBC) and Hepatic Encephalopathy (HE).
Disorders
![umecrine-disorders-image (1)](https://www.umecrinecognition.com/en/wp-content/uploads/sites/2/2021/12/umecrine-disorders-image-1.jpg)
Golexanolone is currently under development for the treatment of two disorders –
Primary Biliary Cholangitis (PBC) and Hepatic Encephalopathy (HE).